Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Relative cardiovascular and gastrointestinal safety of non-selective non-steroidal anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors: implications for clinical practice.

Patrício JP, Barbosa JP, Ramos RM, Antunes NF, de Melo PC.

Clin Drug Investig. 2013 Mar;33(3):167-83. doi: 10.1007/s40261-013-0052-6. Review.

PMID:
23338974
[PubMed - indexed for MEDLINE]
2.

Cyclooxygenase-2 inhibitors: what went wrong?

James MJ, Cleland LG.

Curr Opin Clin Nutr Metab Care. 2006 Mar;9(2):89-94. Review.

PMID:
16477171
[PubMed - indexed for MEDLINE]
3.

COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.

Fiorucci S, Distrutti E.

Curr Med Chem. 2011;18(23):3494-505.

PMID:
21756233
[PubMed - indexed for MEDLINE]
4.
5.

Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.

Vardeny O, Solomon SD.

Cardiol Clin. 2008 Nov;26(4):589-601. doi: 10.1016/j.ccl.2008.06.004.

PMID:
18929233
[PubMed - indexed for MEDLINE]
6.

Coxibs: a significant therapeutic opportunity.

Gatti D, Adami S.

Acta Biomed. 2010 Dec;81(3):217-24. Review.

PMID:
22530460
[PubMed - indexed for MEDLINE]
7.

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.

Moore RA, Derry S, McQuay HJ.

BMC Musculoskelet Disord. 2007 Aug 3;8:73.

PMID:
17683540
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis.

Jones P, Lamdin R.

Clin Drug Investig. 2010;30(7):419-37. doi: 10.2165/11533350-000000000-00000. Review.

PMID:
20527999
[PubMed - indexed for MEDLINE]
9.

Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.

Hermann M, Ruschitzka F.

Ann Med. 2007;39(1):18-27. Review.

PMID:
17364448
[PubMed - indexed for MEDLINE]
10.

Cardiovascular adverse effects of anti-inflammatory drugs.

Roubille C, Martel-Pelletier J, Davy JM, Haraoui B, Pelletier JP.

Antiinflamm Antiallergy Agents Med Chem. 2013 Mar;12(1):55-67. Review.

PMID:
23286294
[PubMed - indexed for MEDLINE]
11.

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

Coxib and traditional NSAID Trialists' (CNT) Collaboration, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C.

Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.

PMID:
23726390
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Non-steroidal anti-inflammatory drug use in the elderly.

Pilotto A, Sancarlo D, Addante F, Scarcelli C, Franceschi M.

Surg Oncol. 2010 Sep;19(3):167-72. doi: 10.1016/j.suronc.2009.11.014. Epub 2009 Dec 21. Review.

PMID:
20022240
[PubMed - indexed for MEDLINE]
13.

NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.

Fiorucci S, Santucci L, Distrutti E.

Dig Liver Dis. 2007 Dec;39(12):1043-51. Epub 2007 Nov 7. Review.

PMID:
17997373
[PubMed - indexed for MEDLINE]
14.

Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.

Austin MS, Abdul-Hadi O, Parvizi J, Viscusi ER, Einhorn T.

Instr Course Lect. 2009;58:759-68.

PMID:
19385584
[PubMed - indexed for MEDLINE]
15.

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.

Lanas A, García-Rodríguez LA, Arroyo MT, Gomollón F, Feu F, González-Pérez A, Zapata E, Bástida G, Rodrigo L, Santolaria S, Güell M, de Argila CM, Quintero E, Borda F, Piqué JM; Asociación Española de Gastroenterología.

Gut. 2006 Dec;55(12):1731-8. Epub 2006 May 10.

PMID:
16687434
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S.

Arthritis Rheum. 2006 May;54(5):1378-89.

PMID:
16645966
[PubMed - indexed for MEDLINE]
Free Article
17.

Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.

Hur C, Chan AT, Tramontano AC, Gazelle GS.

Ann Pharmacother. 2006 Jun;40(6):1052-63. Epub 2006 May 23.

PMID:
16720709
[PubMed - indexed for MEDLINE]
18.
19.

Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.

Sostres C, Gargallo CJ, Arroyo MT, Lanas A.

Best Pract Res Clin Gastroenterol. 2010 Apr;24(2):121-32. doi: 10.1016/j.bpg.2009.11.005. Review.

PMID:
20227026
[PubMed - indexed for MEDLINE]
20.

Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor.

Bannwarth B, Berenbaum F.

Expert Opin Investig Drugs. 2005 Apr;14(4):521-33. Review.

PMID:
15882125
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk